RecruitingPhase 2NCT05870111
Citicoline in Youth Alcohol Use Disorder
Neurobehavioral and Immune Effects of Citicoline in Youth Alcohol Use Disorder
Sponsor
Medical University of South Carolina
Enrollment
56 participants
Start Date
Oct 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this study is to evaluate how citicoline, an over-the-counter supplement, versus a placebo pill (i.e., an inactive pill) affects the immune system, brain, and cognition in adolescents who may use alcohol.
Eligibility
Min Age: 16 YearsMax Age: 22 Years
Inclusion Criteria2
- Age 16 to 22.
- Call study team for additional screening and information.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGCiticoline (cytidine diphosphate-choline)
2000mg/day citicoline, administered orally, for 4 weeks
DRUGPlacebo oral capsule
placebo capsule daily for 4 weeks, matched in appearance to citicoline to preserve double-blind, administered orally
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05870111
Related Trials
Environment and Alcohol: A Pilot Study
NCT068606071 location
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
NCT070278391 location
Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
NCT065527411 location
NIAAA Natural History Protocol
NCT022318401 location
Semaglutide Therapy for Alcohol Reduction (STAR)
NCT060158931 location